The Law Offices of Vincent Wong
SHAREHOLDER ALERT: TUSK RMED FDX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
Monday, July 22, 2019 1:45 PM
NEW YORK, NY / ACCESSWIRE / July 22, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.
Mammoth Energy Services, Inc. (NASDAQ: TUSK)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/mammoth-energy-services-inc-loss-submission-form?prid=2533&wire=1
Lead Plaintiff Deadline: August 9, 2019
Class Period: October 19, 2017 to June 5, 2019
Allegations against TUSK include that: (1) Mammoth’s subsidiary, Cobra, improperly obtained two infrastructure contracts with PREPA that totaled over $1.8 billion; (2) specifically, the contracts were awarded as the result of improper steering and not a competitive RFP process; and (3) as a result, Defendants’ statements about Mammoth’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Ra Medical Systems, Inc. (NYSE: RMED)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/ra-medical-systems-inc-loss-submission-form?prid=2533&wire=1
Lead Plaintiff Deadline: August 6, 2019
Class Period: stockholders that purchased Ra Medical securities pursuant and/or traceable to the Company’s September 2018 initial public offering.
Allegations against RMED include that: (1) the Company’s evaluation of sales personnel candidates was inadequate; (2) the Company’s training program for sales personnel was inadequate; (3) as a result, the Company could not reasonably assure that its newly hired sales personnel were adequately experienced; (4) as a result, the Company would suffer a shortage of qualified sales personnel; (5) the Company’s manufacturing process could not reasonably support increased catheter production; (6) as a result, the Company would suffer production delays; and (7) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
FedEx Corporation (NYSE: FDX)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/fedex-corporation-loss-submission-form?prid=2533&wire=1
Lead Plaintiff Deadline: August 26, 2019
Class Period: September 19, 2017 to December 18, 2018
Allegations against FDX include that: (1) TNT’s overall package volume growth was slowing as TNT’s large customers permanently took their business to competitors after the Cyberattack; (2) as a result of the customer attrition, TNT was experiencing an increased shift in product mix from higher-margin parcel services to lower-margin freight services; (3) the anticipated costs and timeframe to integrate and restore the TNT network were significantly larger and longer than disclosed; (4) FedEx was not on track to achieve TNT synergy targets; and (5) as a result of these undisclosed negative trends and cost issues, FedEx’s positive statements about TNT’s recovery from the Cyberattack, integration into FedEx’s legacy operations, customer mix, customer service levels, profitability, and prospects lacked a reasonable basis.
To learn more contact Vincent Wong, Esq. either via email [email protected] or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
Vincent Wong, Esq.
39 East Broadway
New York, NY 10002
E-Mail: [email protected]
SOURCE: The Law Offices of Vincent Wong